Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

BACKGROUND: PYRAMID was an international multicenter, noninterventional, postmarketing registry assessing long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice. METHODS: Adult patients with moderately to severely active Crohn’s disease with or without prior...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Inflamm Bowel Dis
Päätekijät: Loftus, Edward V, Reinisch, Walter, Panaccione, Remo, Berg, Sofie, Alperovich, Gabriela, Bereswill, Mareike, Kalabic, Jasmina, Petersson, Joel, Thakkar, Roopal, Robinson, Anne M, D’Haens, Geert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Original Clinical Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701510/
https://ncbi.nlm.nih.gov/pubmed/30753510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia